Monitoring and reporting
The Conference of the Parties serving as the meeting of the
Parties to the Cartagena Protocol on Biosafety,
Recalling its decision BS-I/9, on monitoring and
reporting under the Protocol,
Recalling also paragraph 6 (a) of the annex to its
decision BS-I/12, on the medium‑term programme of work, providing
for it to consider at its fourth meeting the first regular national
reports by Parties on the implementation of the Protocol,
Taking note of the interim national reports submitted
by Parties, and welcoming the analysis thereof prepared by
the Secretariat (UNEP/CBD/BS/COP-MOP/3/12),
Emphasizing the importance of fulfilling monitoring and
reporting obligations under Article 33 of the Protocol,
particularly with regard to its interconnection with
capacity-building, promoting compliance, and assessment and
review,
Recognizing the need for capacity‑building to enable
developing country Parties, in particular the least developed and
small island developing States among them, as well as Parties with
economies in transition, to fulfil their national reporting
obligations under the Protocol,
1. Adopts the national reporting format annexed to the
present decision ;
2. Reminds each Party to fulfil its monitoring and
reporting obligations and to ensure that its national reports
provide information that adequately respond to the questionnaire in
the reporting format and invites eligible Parties that may
face difficulties in the preparation of their national reports to
make these difficulties known to the Secretariat and to seek
assistance from any available opportunities such as the roster of
experts;
3. Requests Parties to submit their first regular
national report, covering the period between entry into force of
the Protocol for each Party and the reporting date, 12 months prior
to its fourth meeting, to allow consideration of the reports at
that meeting;
4. Reminds Parties that not submitting a national
report within the deadline does not absolve them from fulfilling
their obligation for that reporting period;
5. Invites developed country Parties, other Governments
as well as relevant organizations to provide financial and
technical support for capacity-building to enable developing
country Parties, in particular the least developed and small island
developing States among them, as well as Parties with economies in
transition to meet their reporting obligations under the
Protocol;
6. Invites the Global Environment Facility to make
available financial resources to facilitate the consultative
information-gathering process leading to the preparation of
national reports for those developing country Parties, in
particular the least developed and small island developing States
among them, and Parties with economies in transition, which lack
sufficient capacity in this regard;
7. Requests the Executive Secretary to prepare, in time
for the fourth meeting of the Conference of the Parties serving as
the meeting of the Parties to the Protocol, an analysis based on
the information contained in national reports received.
Annex
FORMAT FOR THE FIRST REGULAR
NATIONAL REPORT ON THE IMPLEMENTATION OF THE CARTAGENA PROTOCOL ON
BIOSAFETY
GUIDELINES FOR USE OF THE REPORTING
FORMAT
The following format for preparation of the first regular
national report on implementation of the Cartagena Protocol on
Biosafety called for under Article 33 of the Protocol is a series
of questions based on those elements of the Protocol that establish
obligations for Contracting Parties. Responses to these questions
will help Parties to review the extent to which they are
successfully implementing the provisions of the Protocol and will
assist the Conference of the Parties serving as the meeting of the
Parties to the Protocol to assess the overall status of
implementation of the Convention.
The deadline for submission of the first regular national report
is no less than 12 months prior to the fourth meeting of Conference
of the Parties serving as the meeting of the Parties to the
Protocol. It is intended to cover activities undertaken between
entry into force of the Protocol for the reporting Party and the
date of reporting.
F or subsequent national reports, the format is expected to
evolve, as questions that are no longer relevant after the first
national report may be deleted, questions that are relevant to
ongoing progress in implementation will be retained, and additional
questions will be formulated pursuant to future decisions of the
Conference of the Parties serving as the meeting of the Parties to
the Protocol.
The wording of questions follows the wording of the relevant
articles of the Protocol as closely as possible. The use of terms
in the questions follows the meanings accorded to them under
Article 3 of the Protocol .
The format tries to minimize the reporting burden on Pa rties,
while eliciting the important information regarding implementation
of the provisions of the Protocol. Many questions require only a
tick in one or more boxes. 1 / Other questions seek a qualitative
description of experiences and progress, including obstacles and
impediments to the implementation of particular provisions. 2 / Although there
is no set limit on length of text, in order to assist with the
review and synthesis of the information in the reports, respondents
are asked to ensure that answe rs are as relevant and as succinct
as possible.
The information provided by Parties will not be used to rank
performance or to otherwise compare implementation between
individual Parties.
The Executive Secretary welcomes any comments on the adequacy of
the questions, and difficulties in completing the questions, and
any further recommendations on how these reporting guidelines could
be improved. Space is provided for such comments at the end of the
report .
It is recommended that Parties involve all relev ant
stakeholders in the preparation of the report, in order to ensure a
participatory and transparent approach to its development and the
accuracy of the information requested. A box is provided in which
to identify those groups who have been involved.
Parties are requested to submit an original signed copy by post
and an electronic copy on diskette or by electronic mail. An
electronic version of this document will be sent to all national
focal points and this will also be available from the Convention's
website at: http://www.biodiv.org
Completed reports and any comments should be sent to:
The Executive Secretary
Secretariat of the Convention on Biological Diversity
World Trade Centre
413 St. Jacques Street West, suite 800
Montreal , Quebec
H2Y 1N9 Canada
Fax: (+1 514) 288 6588
e-mail: [email protected]
|
Party: | |
Contact officer for report |
Name and title of contact officer: | |
Mailing address: | |
Telephone: | |
Fax: | |
E-mail: | |
Submission |
Signature of officer responsible for submitting report: | |
Date of submission: | |
Time period covered by this report: | |
Please provide summary information on the process by which this
report has been prepared, including information on the types of
stakeholders who have been actively involved in i ts preparation
and on material which was used as a basis for the report:
Obligations for provision of
information to the Biosafety Clearing-House
1. Several articles of the Protocol require that information be
provided to the Biosafety Clearing-House (see the list below). For
your Government, if there are cases where relevant information
exists but has not been provided to the Biosafety Clearing-House
(BCH), describe any obstacles or impediments encountered regarding
provision of that information (note: To answer this question,
please check the BCH to determine the current status of your
country's information submissions relative to the list of required
information below. If you do not have access to the BCH, contact
the Secretariat for a summary): |
|
| 2. Please provide an
overview of inform ation that is required to be provided to the
Biosafety Clearing-House: |
Type of information | Information exists and is being
provided to the Biosafety Clearing-House | Information exists but is not yet
provided to the Biosafety Clearing-House | Information does not exist /not
applicable |
(a) Existing national legislation,
regulations and guidelines for implementing the Protocol, as well
as information required by Parties for the advance informed
agreement procedure (Article 20.3(a) ) | | | |
(b) National laws, regulations and
guidelines applicable to the import of LMOs intended for direct use
as food or feed, or for processing (Article 11.5); | | | |
(c) Bilateral, multilateral and
regional agreements and arrangements (Articles 14.2, 20.3(b), and
24.1); | | | |
(d) Con tact details for competent
national authorities (Articles 19.2 and 19.3), national focal
points (Articles 19.1 and 19.3), and emergency contacts (Article
17.2 and 17.3(e)); | | | |
(e) In cases of multiple competent
national authorities, responsibilities for each (Art icles 19.2 and
19.3); | | | |
(f) Reports submitted by the Parties on
the operation of the Protocol (Article 20.3(e)); | | | |
(g) Occurrence of unintentional
transboundary movements that are likely to have significant adverse
effects on biological diversity (Article 17.1); | | | |
Type of information | Information exists and is being
provided to the Biosafety Clearing-House | Information exists but is not yet
provided to the Biosafety Clearing-House | Information does not exist /not
applicable |
(h) Ille gal transboundary movements of
LMOs (Article 25.3); | | | |
(i) Final decisions regarding the
importation or release of LMOs (i.e. approval or prohibition, any
conditions, requests for further information, extensions granted,
reasons for decision) (Articles 10.3 and 2 0.3(d)); | | | |
(j) Information on the application of
domestic regulations to specific imports of LMOs (Article
14.4); | | | |
(k) Final decisions regarding the
domestic use of LMOs that may be subject to transboundary movement
for direct use as food or feed, or for processing ( Article
11.1); | | | |
(l) Final decisions regarding the
import of LMOs intended for direct use as food or feed, or for
processing that are taken under domestic regulatory frameworks
(Article 11.4) or in accordance with annex III (Article 11.6)
(requirement of Article 20.3(d)) | | | |
(m) Declarations regarding the
framework to be used for LMOs intended for direct use as food or
feed, or for processing (Article 11.6) | | | |
(n) Review and change of decisions
regarding intentional transboundary movements of LMOs (Article
12.1); | | | |
(n) LMOs granted e xemption status by
each Party (Article 13.1) | | | |
(o) Cases where intentional
transboundary movement may take place at the same time as the
movement is notified to the Party of import (Article 13.1); | | | |
(p) Summaries of risk assessments or
environmental reviews of LMO s generated by regulatory processes
and relevant information regarding products thereof (Article
20.3(c)). | | | |
Article 2 - General
provisions
3. Has your country introduced the necessary legal,
administrative and other measures for implementation of the
Protocol? (Article 2.1) |
a) full domestic regulatory framework in place (please give
details below)
| |
b) some measures introduced (please give details below)
| |
c) no measures yet taken
| |
4. Please provide further details about your response to the
above question, as well as description of your country's
experiences and progress in implementing Article 2, including any
obstacles or impediments encountered: |
|
Articles 7 to 10 and 12: The
advance informed agreement procedure
See question 1 r egarding provision
of information to the Biosafety Clearing-House.
5. Were you a Party of import during this reporting period? |
a) yes
| |
b) no
| |
6. Were you a Party of export during this reporting period? |
a) yes
| |
b) no
| |
7. Is there a legal requirement for the accuracy of information
provided by exporters 3 / under the jurisdiction of your country? (
Article 8.2) |
a) yes
| |
b) not yet, but under development
| |
c) no
| |
d) not applicable - not a Part y of export
| |
8. If you were a Party of export during this reporting period,
did you request any Party of import to review a decision it had
made under Article 10 on the grounds specified in Article 12.2? |
a) yes (please give details below)
| |
b) not yet, but under development
| |
c) no
| |
d) not applicable - not a Party of export
| |
9. Did your country take decisions regarding import under
domestic regulatory frameworks as allowed by Article 9.2(c). |
a) yes
| |
b) no
| |
c) not applicable - no decisions taken during the reporting
period
| |
10. If your country has been a Party of export of LMOs intended
for release into the environment during the reporting period,
please describe your experiences and progress in implementing
Articles 7 to 10 and 12, including any obstacles or impediments
encountered: |
|
11. If your country has taken decisions on import of LMOs
intended for release into the environment during the reporting
period, please describe your experiences and progress in
implementing Articles 7 to 10 and 12, including any obstacles or
impediments encountered: |
|
Article 11 - Procedure for
living modified organisms intended for direct use as food or feed,
or for processing
See question 1 regarding provision of
information to the Biosafety Clearing-House.
12. Is there a legal requirement for the accuracy of information
provided by the applicant with respect to the domestic use of a
living modified organism that may be subject to transboundary
movement for direct use as food or feed, or for processing?
(Article 11.2) |
a) yes
| |
b) not yet, but under development
| |
c) no
| |
d) not applicable (pl ease give details below)
| |
13. Has your country indicated its needs for financial and
technical assistance and capacity‑building in respect of living
modified organisms intended for direct use as food or feed, or for
processing? (Article 11.9) |
a) yes (please give details below)
| |
b) no
| |
c) not relevant
| |
14. Did your country take decisions regarding import under
domestic regulatory frameworks as allowed by Article 11.4? |
a) yes
| |
b) no
| |
c) not applicable - no decisions taken during the reporting
period
| |
15. If your country has been a Party of export of LMOs intended
for direct use for food or feed, or for processing, during the
reporting period, please describe your experiences and progress in
implementing Article 11, including any obstacles or impediments
encountered: |
|
16. If your country has been a Party of import of LMOs intended
for direct use for food or feed, or for processing, during the
reporting period, please describe your experiences and progress in
implementing Article 11, including any obstacles or impediments
encountered: |
|
Article 13 - Simplified
procedure
See question 1 regarding provision of
information to the Biosafety Clearing-House.
17. Have you applied the simplified procedure during the
reporting period? |
a) yes
| |
b) no
| |
18. If your country has used the simplified procedure during the
reporting period, or if you have been unable to do so for some
reason, please describe your experiences in implementing Article
13, including any obstacles or impediments encountered: |
|
Article 14 - Bilateral, regional
and multilateral agreements and arrangements
See question 1 regarding provision of
information to the Biosafety Clear ing-House.
19. Has your country entered into any bilateral, regional or
multilateral agreements or arrangements? |
a) yes
| |
b) no
| |
20. If your country has entered into bilateral, regional or
multilateral agreements or arrangements, or if you have been unable
to do so for some reason, describe your experiences in implementing
Article 14 during the reporting period, including any obstacles or
impediments encountered: |
|
Articles 15 and 16 - Risk
assessment and risk management
21. If you were a Party of import during this reporting period,
were risk assessments carried out for all decisions taken under
Article 10? (Article 15.2) |
a) yes
| |
b) no (please clarify below)
| |
c) not a Party of import / no decisions taken under Article
10
| |
22. If yes to question 21 , did you require the exporter to
carry out the risk assessment? |
a) yes - in all cases
| |
b) yes - in some cases (please specify the number and give
further details below)
| |
c) no
| |
d) not a Party of import / no decisions taken under Article
10
| |
23. If you took a decision under Article 10 during the reporting
period, did you require the notifier to bear the cost of the risk
assessment? (Article 15.3) |
a) yes - in all cases
| |
b) yes - in some cases (please specify the number and give
further details below)
| |
c) no
| |
d) not a Party of import / no decisions taken under Article
10
| |
24. Has your country established and maintained appropriate
mechanisms, measures and strategies to regulate, manage and control
risks identified in the risk assessment provisions of the Protocol?
(Article 16.1) |
a) yes - fully established
| |
b) not yet, but under development or partially established
(please give further details below)
| |
c) no
| |
25. Has your country adopted appropriate measures to prevent
unintentional transboundary movements of living modified organisms?
(Article 16.3) |
a) yes - fully adopted
| |
b) not yet, but under development or partially adopted (please
give further details below)
| |
c) no
| |
26. Does your country endeavour to ensure that any living
modified organism, whether imported or locally developed, undergoes
an appropriate period of observation commensurate with its
life-cycle or generation time before it is put to its intended use?
(Article 16.4) |
a) yes - in all cases
| |
b) yes - in some cases (please give further details below)
| |
c) no (please give further details b elow)
| |
d) not applicable (please give further details below)
| |
27. Has your country cooperated with others for the purposes
specified in Article 16.5? |
a) yes (please give further details below)
| |
b) no (please give further details below)
| |
28. Please provide further details about your responses to the
above questions, as well as description of your country's
experiences and progress in implementing Articles 15 and 16,
including any obstacles or impediments encountered: |
|
Article 17 - Unintentional tr
ansboundary movements and emergency measures
See question 1 regarding provision of
information to the Biosafety Clearing-House.
29. During the reporting period, if there were any occurrences
under your jurisdiction that led, or could have led, to an
unintentional transboundary movement of a living modified organism
that had, or could have had, significant adverse effects on the
conservation and sustainable use of biological diversity, taking
also into account risks to human health in such States, did you
immediately consult the affected or potentially affected States for
the purposes specified in Article 17.4? |
a) yes - all relevant States immediately
| |
b) yes - partially consulted, or consultations were delayed
(please clarify below)
| |
c) no - did not consult immediately (please clarify below)
| |
d) not applicable (no such occurrences)
| |
30. Please provide further details about your response to the
above question, as well as description of your country's
experiences in implementing Article 17, including any obstacles or
impediments encountered: |
|
Article 18 - Handling,
transport, packaging and identification
31. Has your country taken measures to require that living
modified organisms that are subject to transboundary movement
within the scope of the Protocol are handled, packaged and
transported under conditions of safety, taking into account
relevant international rules and standards? (Article 18.1) |
a) yes (please give details below)
| |
b) not yet, but under development
| |
c) no
| |
d) not applicable (please clarify below)
| |
32. Has your country taken measures to require that
documentation accompanying living modified organisms for direct use
as food or feed, or for processing, clearly identifies that they
'may contain' living modified organisms and are not intended for
intentional introduction into the environment, as well as a contact
point for information? (Article 18.2(a)) |
a) yes
| |
b) not yet, but under development
| |
c) no
| |
33. Has your country taken measures to require that
documentation accompanying living modified organisms that are
destined for contained use clearly identifies them as living
modified organisms and specifies any requirements for the safe
handling, storage, transport and use, the contact point for further
information, including the name and address of the individual and
institution to whom the living modified organisms are consigned?
(Article 18.2(b)) |
a) yes
| |
b) not yet, but under development
| |
c) no
| |
34. Has your country adopted measures to require that
documentation accompanying living modified organisms that are
intended for intentional introduction into the environment of the
Party of import and any other living modified organisms within the
scope of the Protocol, clearly identifies them as living modified
organisms; specifies the identity and relevant traits and/or
characteristics, any requirements for the safe handling, storage,
transport and use, the contact point for further information and,
as appropriate, the name and address of the importer and exporter;
and contains a declaration that the movement is in conformity with
the requirements of this Protocol applicable to the exporter?
(Article 18.2(c)) |
a) yes
| |
b) not yet, but under development
| |
c) no
| |
35. Please provide further details about your responses to the
above questions, as well as a description of your country's
experiences and progress in implementing Article 18, including any
obstacles or impediments encountered: |
|
Article 19 - Competent national
authorities and national focal points
See question 1 regarding provision of
information to the Biosafety Clearing-House.
Article 20 - Information-sharing
and the Biosafety Clearing-House
See question 1 regarding provision of
information to the Biosafety Clearing-House.
36. In addition to the response to question 1 , please describe
any further details regarding your country's experiences and
progress in implementing Article 20, including any obstacles or
impediments encountered: |
|
Article 21 - Confidential
information
37. Does your country have procedures to protect confidential
information received under the Protocol and that protect the
confidentiality of such information in a manner no less favourable
than its treatment of confidential information in connection with
domestically produced living modified organisms? (Article 21.3) |
a) yes
| |
b) not yet, but under development
| |
c) no
| |
38. If you were a Party of import during this reporting period,
did you permit any notifier to identify information submitted under
the procedures of the Protocol or required by the Party of import
as part of the advance informed agreement procedure that was to be
treated as confidential? (Article 21.1) |
a) yes
| |
If yes, please give number of cases
| |
b) no
| |
c) not applicable - not a Party of import / no such requests
received
| |
39. If you answered yes to the previous question, please provide
information on your experience including description of any
impediments or difficulties encountered: |
|
40. If you were a Party of export during this reporting period,
please describe any impediments or difficulties encountered by you,
or by exporters under your jurisdiction if information is
available, in the implementation of the requirements of Article
21: |
|
Article 22 -
Capacity-building
41. If a developed country Party, during this reporting period
has your country cooperated in the development and/or strengthening
of human resources and institutional capacities in biosafety for
the purposes of the effective implementation of the Protocol in
developing country Parties, in particular the least developed and
small island developing States among them, and in Parties with
economies in transition? |
a) yes (please give details below)
| |
b) no
| |
b) not applicable - not a developed country Party
| |
42. If yes to question 41 , how has such cooperation taken
place: |
|
43. If a developing country Party, or Party with an economy in
transition, during this reporting period has your country
contributed to the development and/or strengthening of human
resources and institutional capacities in biosafety for the
purposes of the effective implementation of the Protocol in another
developing country Party or Party with an economy in
transition? |
a) yes (please give details below)
| |
b) no
| |
b) not applicable - not a developing country Party
| |
44. If yes to question 43 , how has such cooperation taken
place: |
|
45. If a developing country Party or a Party with an economy in
transition, have you benefited from cooperation for technical and
scientific training in the proper and safe management of
biotechnology to the extent that it is required for biosafety? |
a) yes - capacity-building needs fully met (please give details
below)
| |
b) yes - capacity-building needs partially met (please give
details below)
| |
c) no - capacity-building needs remain unmet (please give
details below)
| |
b) no - we have no unmet capacity-building needs in this
area
| |
e) not applicable - not a developing country Party or a Party
with an economy in transition
| |
46. If a developing country Party or a Party with an economy in
transition, have you benefited from cooperation for technical and
scientific training in the use of risk assessment and risk
management for biosafety? |
a) yes - capacity-building needs fully met (please give details
below)
| |
b) yes - capacity-building needs partially met (please give
details below)
| |
c) no - capacity-building needs remain unmet (please give
details below)
| |
b) no - we have no unmet capacity-bui lding needs in this
area
| |
e) not applicable - not a developing country Party or a Party
with an economy in transition
| |
47. If a developing country Party or a Party with an economy in
transition, have you benefited from cooperation for technical and
scientific training for enhancement of technological and
institutional capacities in biosafety? |
a) yes - capacity-building needs fully met (please give details
below)
| |
b) yes - capacity-building needs partially met (please give
details below)
| |
c) no - capacity -building needs remain unmet (please give
details below)
| |
b) no - we have no unmet capacity-building needs in this
area
| |
e) not applicable - not a developing country Party or a Party
with an economy in transition
| |
48. Please provide further details about your responses to the
above questions, as well as description of your country's
experiences and progress in implementing Article 22, including any
obstacles or impediments encountered: |
|
Article 23 - Public awareness
and parti cipation
49. Does your country promote and facilitate public awareness,
education and participation concerning the safe transfer, handling
and use of living modified organisms in relation to the
conservation and sustainable use of biological diversity, taking
also into account risks to human health? (Article 23.1(a)) |
a) yes - significant extent
| |
b) yes - limited extent
| |
c) no
| |
50. If yes, do you cooperate with other States and international
bodies? |
a) yes - significant extent
| |
b) yes - limited extent
| |
c) no
| |
51. Does your country endeavour to ensure that public awareness
and education encompass access to information on living modified
organisms identified in accordance with the Protocol that may be
imported? (Article 23.1(b)) |
a) yes - fully | |
b) yes - limited extent | |
c) no | |
52. Does your country, in accordance with its respective laws
and regulations, consult the public in the decision-making process
regarding living modified organisms and make the results of such
decisions available to the public? (Article 23.2) |
a) yes - fully
| |
b) yes - limited extent
| |
c) no
| |
53. Has your country informed its public about the means of
public access to the Biosafety Clearing-House? (Article 23.3) |
a) yes - fully
| |
b) yes - limited extent
| |
c) no
| |
54. Please provide further details about your responses to the
above questions, as well as description of your country's
experiences and progress in implementing Article 23, including any
obstacles or impediments encountered: |
|
Article 24 -
Non-Parties
See question 1 regarding provision of
information to the Biosafety Clearing-House .
55. Have there been any transboundary movements of living
modified organisms between your country and a non-Party during the
reporting period? |
a) yes
| |
b) no
| |
56. If there have been transboundary movements of living
modified organisms between your country and a non-Party, please
provide information on your experience, including description of
any impediments or difficulties encountered: |
|
Article 25 - Illegal
transboundary movements
See question 1 regarding provision of
information to the Biosafety Clearing-House.
57. Has your country adopted appropriate domestic measures to
prevent and penalize, as appropriate, transboundary movements of
living modified organisms carried out in contravention of its
domestic measures? (Article 25.1) |
a) yes
| |
b) no
| |
58. Have there been any illegal transboundary movements of
living modified organisms into your country during the reporting
period? |
a) yes
| |
b) no
| |
59. Please provide further details about your response to the
above question, as well as description of your country's
experiences in implementing Article 25, including any obstacles or
impediments encountered: |
|
Article 26 - Socio-economic
considerations
60. If during this reporting period your country has taken a
decision on import, did it take into account socio-economic
considerations arising from the impact of living modified organisms
on the conservation and sustainable use of biological diversity,
especially with regard to the value of biological diversity to
indigenous and local communities? (Article 26.1) |
a) yes - significant extent
| |
b) yes - limited extent
| |
c) no
| |
d) not a Party of import
| |
61. Has your country cooperated with other Parties on research
and information exchange on any socio-economic impacts of living
modified organisms, especially on indigenous and local communities?
( Article 26.2) |
a) yes - significant extent
| |
b) yes - limited extent
| |
c) no
| |
62. Please provide further details about your responses to the
above questions, as well as description of your country's
experiences and progress in implementing Article 26, including any
obstacles or impediments encountered: |
|
Article 28 - Financial mechanism
and resources
63. Please indicate if, during the reporting period, your
Government made financial resources available to other Parties or
received financial resources from other Parties or financial
institutions, for the purposes of implementation of the
Protocol. |
a) yes - made financial resources available to other Parties
| |
b) yes - received finan cial resources from other Parties or
financial institutions
| |
c) both
| |
d) neither
| |
64. Please provide further details about your response to the
above question, as well as description of your country's
experiences, including any obstacles or impediments
encountered: |
|
Other information
65. Please use this box to provide any other information related
to articles of the Protocol, questions in the reporting format, or
other issues related to national implementation of the
Protocol: |
|
Comments on reporting
format
The wording of these questions is based on the Articles of the
Protocol. Please provide information on any difficulties that you
have encountered in interpreting the wording of these
questions:
1 / If you feel
that, in order to properly reflect the circumstances, it is
necessary to tick more than one box, please do so. In this case,
you are encouraged to provide further information in the text
answers that follow to enable any analysis of results to
appropriately reflect the spirit of your answers.
2 / Please feel
free to append to the report further information on any of the
questions.
3 / The use of
terms in the questions follows the meanings accorded to them under
Article 3 of the Protocol.
